# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-197416
Filing Date
2026-04-30
Accepted
2026-04-30 16:22:30
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | septerna_2026_naa_card.htm | DEFA14A | 20634
2 | GRAPHIC | img52463029_0.jpg | GRAPHIC | 2345755
3 | GRAPHIC | img52463029_1.jpg | GRAPHIC | 1002328
| Complete submission text file | 0001193125-26-197416.txt |  | 4471038

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42382 | Film No.: 26925857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)